Levothyroxine Sodium Berlin-Chemie (Levothyroxine Sodium)

The drug is a synthetic form of thyroxine (T4). After oral absorption, it is converted in peripheral tissues to the active hormone triiodothyronine (T3). T3 binds nuclear thyroid hormone receptors, influencing gene expression that increases basal metabolic rate and regulates growth, development, and energy utilization.

The appropriate dose of Levothyroxine Sodium is individualized by the prescribing clinician based on the patient’s age, weight, severity of thyroid deficiency, and laboratory thyroid‑stimulating hormone (TSH) results. Dosage adjustments are made during follow‑up to achieve target hormone levels.

Levothyroxine Sodium is classified as a pregnancy category that is not well defined, but thyroid hormone replacement is often essential for maternal and fetal health. Clinicians usually continue therapy with careful monitoring of thyroid function. Breast‑feeding mothers should also be monitored, as the drug passes into milk in small amounts.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any temperature requirements) and the necessary import documentation.

Levothyroxine Sodium is the standard synthetic T4 formulation used globally and is bioequivalent to other levothyroxine products when taken correctly. Some alternatives contain liothyronine (T3) or a combination of T4/T3, but levothyroxine alone is preferred for most patients because of its stable pharmacokinetic profile and ease of dose titration.

Store tablets at ambient temperature, preferably below 25 °C, in the original container to protect them from moisture, light and excessive heat. Keep the product out of reach of children and do not use if the packaging is damaged or the tablets appear discolored.

Levothyroxine Sodium is taken orally, usually as a single daily dose on an empty stomach. Patients are advised to swallow the tablet with a full glass of water at least 30‑60 minutes before breakfast or any other medication to ensure optimal absorption.

Serious risks include cardiac arrhythmias, angina, and symptoms of overt hyperthyroidism such as severe anxiety, tremor, and heat intolerance. Long‑term overtreatment may lead to bone loss or fractures. Any new chest pain, palpitations, or unexplained weight loss should prompt immediate medical evaluation.

Levothyroxine Sodium should be avoided in patients with known hypersensitivity to levothyroxine or any of the tablet excipients. Caution is required in individuals with untreated adrenal insufficiency, recent myocardial infarction, or uncorrected thyrotoxicosis, as the drug may exacerbate these conditions.